Compared with the more robust associations between 3-month s-IGFBP-1 and long-term poststroke outcomes, this suggests that s-IGFBP-1 measured in the latter stages of stroke recovery is of more value as a prognostic marker of poststroke outcome. This evidence concerns the gene IGFBP1 and stroke disorder.